Darden to Sell Red Lobster Chain for $2.1B
Darden Restaurants agreed to sell its Red Lobster chain to private equity firm Golden Gate Capital for $2.1 billion, as the restaurant operator pushes forward with plans to reshape its portfolio.
AstraZeneca CEO Says Would Consider A Compelling Pfizer Offer
AstraZeneca's chief executive said his company's board would consider a compelling offer from Pfizer, despite turning down previous offers from the firm.
Valeant Plans to Improve Offer for Allergan
Valeant plans to unveil an improved offer for Botox maker Allergan later this month, as the Canadian drug company seeks to rally shareholder support for a buyout.
AT&T Could Close Deal For DirecTV in 2 Weeks: Report
AT&T could seal a deal to acquire satellite television company DirecTV in the next two weeks, according to a report in The Wall Street Journal.
Mondelez to Merge Coffee Unit With D.E. Master Blenders
Mondelez agreed to merge its coffee business with D.E. Master Blenders, forming a new company that can better compete with Nestle and allowing Mondelez to focus on its snack portfolio.
Freeport-McMoRan Sells Eagle Ford Assets for $3.1B
Freeport-McMoRan Copper & Gold will sell its Eagle Ford Shale assets to Canada's Encana for $3.1 billion.
Bayer Scoops Up Merck Consumer-Care Unit for $14B
Merck agreed to sell its consumer-care unit to German pharmaceutical giant Bayer for $14.2 billion, continuing a flurry of healthcare deals.
AstraZeneca Rejects Pfizer’s Sweetened Bid of $106B
AstraZeneca turned down a sweetened buyout offer of $106.4 billion from rival drug giant Pfizer, thwarting a move that would have created the world’s largest pharmaceutical company.
Botox-Maker Allergan Reportedly Seeks Alternate Suitor
Botox-maker Allergan is reportedly hunting for a white knight after Valeant made a hostile buyout offer backed by Bill Ackman.
Zimmer to Buy Biomet in $13.4B Deal
The medical-device maker said it would acquire orthopedic products company Biomet in a deal valued at about $13.35 billion.
Big Pharma Seeking to Reduce Risk, Boost Profits Thru Deals
Pharmaceutical companies have been announcing deals at breakneck speeds this year in what analysts say is an attempt to hedge risk and hike profits.
Novartis Agrees to $25B in Deals With GSK, Lilly to Revamp Portfolio
Novartis said it will swap assets with GlaxoSmithKline and sell its animal health arm in a bid to simplify its business.
Post to Buy Michael Foods for $2.45B
Post Holdings agreed to buy eggs and dairy producer Michael Foods for $2.45 billion, as the cereal maker looks to expand its breakfast portfolio.
Johnson Controls to Pay $1.6B for Air Distribution Technologies
Johnson Controls agreed to a $1.6 billion deal to buy Air Distribution Technologies, adding to the diversified manufacturer’s ventilation business.
SodaStream Pops 11% on Minority Stake Sale Buzz
Shares of SodaStream climbed 11% on a report it's huddling with large soft-drink producers over a minority stake sale.
Mars Scoops Up Swath of P&G Pet Food for $2.9B
Mars agreed to buy a significant portion of Procter and Gamble’s pet-food business for $2.9 billion in cash.
Chicago Cubs IPO? Ricketts Family May Sell Stake to Fund Wrigley Makeover
Hoping to raise cash to renovate 100-year-old Wrigley Field, the Ricketts family is debating selling shares of the Chicago Cubs to minority shareholders.
J-Lo-Backed NuvoTV Buys Fuse Network, Beating Out Sean 'Diddy' Combs
Jennifer Lopez-backed NUVOtv inked a $226 million deal on Friday to acquire Madison Square Garden’s Fuse cable-TV network, beating out hip-hop mogul Sean 'Diddy' Combs.
Report: Yahoo Eyes $300M Buyout of Video Service News Distribution Network
In a bid to narrow the gap with YouTube, Yahoo is reportedly in preliminary talks to acquire online-video service News Distribution Network for roughly $300 million.
Apache to Shed Canadian Assets for $374M
Apache agreed to sell oil and natural gas assets in western Canada for $374 million, as the energy producer continues to shed pieces of its portfolio.

















